
Bioventix PLC – LSE:BVXP.L
Bioventix stock price today
Bioventix stock price monthly change
Bioventix stock price quarterly change
Bioventix stock price yearly change
Bioventix key metrics
Market Cap | 165.46M |
Enterprise value | 157.24M |
P/E | 20.16 |
EV/Sales | 11.55 |
EV/EBITDA | 14.80 |
Price/Sales | 11.99 |
Price/Book | 13.60 |
PEG ratio | 74.60 |
EPS | 2.66 |
Revenue | 21.85M |
EBITDA | 17.18M |
Income | 13.88M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 59.51% |
Oper. margin | 77.89% |
Gross margin | 92.79% |
EBIT margin | 77.89% |
EBITDA margin | 78.63% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBioventix stock price history
Bioventix stock forecast
Bioventix financial statements
Dec 2021 | 2.36M | 1.49M | 63.16% |
---|---|---|---|
Dec 2022 | 5.89M | 3.73M | 63.28% |
Jun 2023 | 6.92M | 4.64M | 67.07% |
Dec 2023 | 6.67M | 4.02M | 60.28% |
Paying a dividend greater than earnings.
Payout ratio | 101.86% |
---|
2016 | 3.96% |
---|---|
2017 | 3.46% |
2019 | 3.21% |
2020 | 3.03% |
2022 | 4.41% |
Dec 2021 | 10628856 | 900.19K | 8.47% |
---|---|---|---|
Sep 2022 | 11710173 | 1.22M | 10.43% |
Dec 2022 | 11710173 | 1.24M | 10.63% |
Dec 2023 | 13148538 | 1.71M | 13.04% |
Dec 2021 | 3.76M | -3.31K | -5.20M |
---|---|---|---|
Dec 2022 | 4.24M | -10.58K | -5.20M |
Jun 2023 | 3.66M | 65.75K | -3.09M |
Dec 2023 | 4.49M | -5.32K | -4.69M |
Bioventix alternative data
Aug 2023 | 12 |
---|---|
Sep 2023 | 12 |
Oct 2023 | 12 |
Nov 2023 | 12 |
Dec 2023 | 12 |
Jan 2024 | 12 |
Feb 2024 | 12 |
Mar 2024 | 12 |
Apr 2024 | 12 |
May 2024 | 12 |
Jun 2024 | 12 |
Jul 2024 | 12 |
Bioventix other data
Insider | Compensation |
---|---|
Mr. Peter John Harrison MA (1958) Chief Executive Officer & Director | $270,810 |
Mr. Bruce Edward Heath Hiscock (1958) Chief Financial Officer & Director | $61,660 |
-
What's the price of Bioventix stock today?
One share of Bioventix stock can currently be purchased for approximately $3,400.
-
When is Bioventix's next earnings date?
Unfortunately, Bioventix's (BVXP.L) next earnings date is currently unknown.
-
Does Bioventix pay dividends?
Yes, Bioventix pays dividends and its trailing 12-month yield is 4.96% with 102% payout ratio.It means that the company is paying a dividend greater than earnings. The last Bioventix stock dividend of $0 was paid on 3 Sep 2025.
-
How much money does Bioventix make?
Bioventix has a market capitalization of 165.46M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 16.1% to 13.61M US dollars.
-
What is Bioventix's stock symbol?
Bioventix PLC is traded on the LSE under the ticker symbol "BVXP.L".
-
What is Bioventix's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Bioventix?
Shares of Bioventix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Bioventix's key executives?
Bioventix's management team includes the following people:
- Mr. Peter John Harrison MA Chief Executive Officer & Director(age: 67, pay: $270,810)
- Mr. Bruce Edward Heath Hiscock Chief Financial Officer & Director(age: 67, pay: $61,660)
-
How many employees does Bioventix have?
As Jul 2024, Bioventix employs 12 workers.
-
When Bioventix went public?
Bioventix PLC is publicly traded company for more then 11 years since IPO on 29 Apr 2014.
-
What is Bioventix's official website?
The official website for Bioventix is bioventix.com.
-
How can i contact Bioventix?
Bioventix can be reached via phone at +44 1252 728001.
Bioventix company profile:

Bioventix PLC
bioventix.comLSE
12
Biotechnology
Healthcare
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.
London, W1W 8DH
:
ISIN: GB00B4QVDF07
CUSIP: G1285U100